Patient Controlled Injectors Market – By Application (Cancer Treatment, Auto-immune Treatment, and Blood Disorders Treatment), By Product (Electronic Wearable Injectors, Mechanical Wearable Injectors, and Infusion Pumps), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Mail Order Pharmacies), and By Region - Global Industry Perspective, Comprehensive Analysis, and Forecast, 2020 – 2026

Published Date: 04-May-2021 Category: Medical Device Report Format : PDF Pages: 130 Report Code: ZMR-6204 Status : Published

The global Patient Controlled Injectors market, which was estimated at about 2,969 (USD Million) in 2019 and is predicted to accrue earnings worth 6,579 (USD Million) by 2026, is set to record a CAGR of nearly over 12.1% during 2020-2026.

Description

The global Patient Controlled Injectors market, which was estimated at about 2,969 (USD Million) in 2019 and is predicted to accrue earnings worth 6,579 (USD Million) by 2026, is set to record a CAGR of nearly over 12.1% during 2020-2026. The report offers valuation and analysis of Patient Controlled Injectors market on a global as well as regional level. The study offers a comprehensive assessment of the industry competition, limitations, sales estimates, avenues, current & emerging trends, and industry-validated market data. The report offers historical data from 2016 to 2019 along with a forecast from 2020 to 2026 based on value (USD Million).

Patient Controlled Injectors Market: An Overview

Patient controlled injector is the breakthrough in injection administration. The medical device helps in fulfilling the unmet requirements of patients as it offers comfort and ease as compared to any other medical equipment. Moreover, the device is ergonomically created and helps in patient in improving self-care, thereby making it easier for the patients in effectively handling & administering the medicines at a prescribed period. Apart from this, the medical device is a subcutaneous drug delivery tool adhering to the patient body along with helping in inoculating huge volumes of medicine.

Global Patient Controlled Injectors Market

Patient Controlled Injectors Market: Growth Drivers

Escalating occurrence of chronic ailments such as autoimmune diseases, cancer, and blood ailments resulting in need for elongate duration of treatment will prompt the growth of patient controlled injectors industry over the assessment period. In addition to this, utility of patient controlled injectors has assisted in mitigating risks of contamination, needle stick injuries, and reducing medical errors caused as a result of parenteral mode of medicine administration through injection. This, in turn, will promulgate the expansion of patient controlled injectors industry over the upcoming years. Breakthroughs in pharma sector resulting in launching of new drug therapies for treating severe disorders will translate into massive demand for patient controlled injectors across the healthcare industry over 2020-2026. Apparently, patient controlled injector provides efficient target drug delivery along with long-term medicine residence to affected regions of heart systems, thereby enhancing the popularity of the product in the recent years.

North America To Make Notable Contributions Towards Overall Market Share By 2026

The regional market growth over 2020-2026 is due to surge in the chronic ailment occurrence requiring patient controlled injectors for inoculating medicines. In addition to this, presence of major participants profiled in the study will drive the regional market trends.

Key participants profiled in the study are Gerresheimer AG, scPharmaceuticals Inc., United Therapeutics Corporation, Westbourne Medical Limited, Enable Injections, Johnson and Johnson Services, Inc., F. Hoffmann-La Roche Ltd., BD, and Ypsomed AG.

The global Patient Controlled Injectors Market is segmented as follows:

By Application:

  • Cancer Treatment
  • Auto-immune Treatment
  • Blood Disorders Treatment

By Product:

  • Electronic Wearable Injectors
  • Mechanical Wearable Injectors
  • Infusion Pumps

By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Mail Order Pharmacies

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

  • Chapter 1. Preface
    • 1.1. Report Description and Scope
    • 1.2. Research Scope
    • 1.3. Research Methodulogy
      • 1.3.1. Market Research Process
      • 1.3.2. Market Research Methodulogy
  • Chapter 2. Executive Summary
    • 2.1. Patient Contrulled Injectors Market, 2016–2026 (USD Million)
    • 2.2. Patient Contrulled Injectors Market: Snapshot
  • Chapter 3. Global Patient Contrulled Injectors Market– Industry Analysis
    • 3.1. Patient Contrulled Injectors Market: Market Dynamics
    • 3.2. Market Drivers
      • 3.2.1. Escalating occurrence of chronic ailments such as autoimmune diseases, cancer, and blood ailments resulting in need for elongated duration of treatment will prompt the growth of patient contrulled injectors industry over the assessment period.
      • 3.2.2. Utility of patient contrulled injectors has assisted in mitigating risks of contamination, needle stick injuries, and reducing medical errors caused as a result of parenteral mode of medicine administration through injection. This, in turn, will promulgate the expansion of patient contrulled injectors industry over the upcoming years.
    • 3.3. Porter’s Five Forces Analysis
    • 3.4. Market Attractiveness Analysis
      • 3.4.1. Market attractiveness analysis By Application
      • 3.4.2. Market attractiveness analysis By Product
      • 3.4.3. Market attractiveness analysis By Distribution Channel
  • Chapter 4. Global Patient Contrulled Injectors Market– Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global Patient Contrulled Injectors Market: company market share, 2018
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New Product launches
      • 4.2.3. Agreements, partnerships, cullaborations, and joint ventures
      • 4.2.4. Research and development and Regional expansion
    • 4.3. Price trend analysis
  • Chapter 5. Global Patient Contrulled Injectors Market– Application Analysis
    • 5.1. Global Patient Contrulled Injectors Market overview: By Application
      • 5.1.1. Global Patient Contrulled Injectors Market share, By Application , 2019 and 2026
    • 5.2. Cancer Treatment
      • 5.2.1. Global Patient Contrulled Injectors Market By Cancer Treatment, 2016–2026 (USD Million)
    • 5.3. Auto-immune Treatment
      • 5.3.1. Global Patient Contrulled Injectors Market By Auto-immune Treatment, 2016–2026 (USD Million)
    • 5.4. Blood Disorders Treatment
      • 5.4.1. Global Patient Contrulled Injectors Market By Blood Disorders Treatment, 2016–2026 (USD Million)
  • Chapter 6. Global Patient Contrulled Injectors Market– Product Analysis
    • 6.1. Global Patient Contrulled Injectors Market overview: By Product
      • 6.1.1. Global Patient Contrulled Injectors Market share, By Product, 2019 and 2026
    • 6.2. Electronic Wearable Injectors
      • 6.2.1. Global Patient Contrulled Injectors Market By Electronic Wearable Injectors, 2016–2026 (USD Million)
    • 6.3. Mechanical Wearable Injectors
      • 6.3.1. Global Patient Contrulled Injectors Market By Mechanical Wearable Injectors, 2016–2026 (USD Million)
    • 6.4. Infusion Pumps
      • 6.4.1. Global Patient Contrulled Injectors Market By Infusion Pumps, 2016–2026 (USD Million)
  • Chapter 7. Global Patient Contrulled Injectors Market– Distribution Channel Analysis
    • 7.1. Global Patient Contrulled Injectors Market overview: By Distribution Channel
      • 7.1.1. Global Patient Contrulled Injectors Market share, By Distribution Channel , 2019 and 2026
    • 7.2. Hospital Pharmacies
      • 7.2.1. Global Patient Contrulled Injectors Market By Hospital Pharmacies, 2016–2026 (USD Million)
    • 7.3. Retail Pharmacies
      • 7.3.1. Global Patient Contrulled Injectors Market By Retail Pharmacies, 2016–2026 (USD Million)
    • 7.4. Mail Order Pharmacies
      • 7.4.1. Global Patient Contrulled Injectors Market By Mail Order Pharmacies, 2016–2026 (USD Million)
  • Chapter 8. Company Profiles
    • 8.1. Gerresheimer AG
      • 8.1.1. Overview
      • 8.1.2. Financials
      • 8.1.3. Product Portfulio
      • 8.1.4. Business Strategy
      • 8.1.5. Recent Developments
    • 8.2. scPharmaceuticals Inc.
      • 8.2.1. Overview
      • 8.2.2. Financials
      • 8.2.3. Product Portfulio
      • 8.2.4. Business Strategy
      • 8.2.5. Recent Developments
    • 8.3. United Therapeutics Corporation
      • 8.3.1. Overview
      • 8.3.2. Financials
      • 8.3.3. Product Portfulio
      • 8.3.4. Business Strategy
      • 8.3.5. Recent Developments
    • 8.4. F. Hoffmann-La Roche Ltd.
      • 8.4.1. Overview
      • 8.4.2. Financials
      • 8.4.3. Product Portfulio
      • 8.4.4. Business Strategy
      • 8.4.5. Recent Developments
    • 8.5. BD
      • 8.5.1. Overview
      • 8.5.2. Financials
      • 8.5.3. Product Portfulio
      • 8.5.4. Business Strategy
      • 8.5.5. Recent Development
    • 8.6. Ypsomed AG
      • 8.6.1. Overview
      • 8.6.2. Financials
      • 8.6.3. Product Portfulio
      • 8.6.4. Business Strategy
      • 8.6.5. Recent Development
    • 8.7. Johnson and Johnson Services, Inc.
      • 8.7.1. Overview
      • 8.7.2. Financials
      • 8.7.3. Product Portfulio
      • 8.7.4. Business Strategy
      • 8.7.5. Recent Development

Methodology


Frequently Asked Questions

Escalating occurrence of chronic ailments such as autoimmune diseases, cancer, and blood ailments resulting in need for elongate duration of treatment will prompt the growth of patient controlled injectors industry over the assessment period. In addition to this, utility of patient controlled injectors has assisted in mitigating risks of contamination, needle stick injuries, and reducing medical errors caused as a result of parenteral mode of medicine administration through injection. This, in turn, will promulgate the expansion of patient controlled injectors industry over the upcoming years. Breakthroughs in pharma sector resulting in launching of new drug therapies for treating severe disorders will translate into massive demand for patient controlled injectors across the healthcare industry over 2020-2026. Apparently, patient controlled injector provides efficient target drug delivery along with long-term medicine residence to affected regions of heart systems, thereby enhancing the popularity of the product in the recent years.

According to Zion Market Research report, the global Patient Controlled Injectors market, which was estimated at about 2,969 (USD Million) in 2019 and is predicted to accrue earnings worth 6,579 (USD Million) by 2026, is set to record a CAGR of nearly over 12.1% during 2020-2026.  

North America is likely to make noteworthy contributions towards overall market revenue. The growth of the industry in the sub-continent over the estimated timespan is attributed to surge in the chronic ailment occurrence requiring patient controlled injectors for inoculating medicines. In addition to this, presence of major participants profiled in the study will drive the regional market trends.

The key players profiled in the report include are Gerresheimer AG, scPharmaceuticals Inc., United Therapeutics Corporation, Westbourne Medical Limited, Enable Injections, Johnson and Johnson Services, Inc., F. Hoffmann-La Roche Ltd., BD, and Ypsomed AG.

 

Office Address

Corporate Office
Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office
3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #
US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com